Search clinical trials for: Renal Plasma Flow

Total 28662 results

University of Nebraska
National Cancer Institute (NCI)

Withdrawn

Talabostat in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer
SWOG Cancer Research Network
National Cancer Institute (NCI)

Suspended

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Stage II Bladder Cancer AJCC v8 | Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall | Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma

United States
Hospital Civil de Guadalajara

Active, not recruiting

Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury

Acute Kidney Injury | Anemia, Iron Deficiency

Mexico
University of Chicago

Completed

Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study

AKI

United States
Outset Medical
White Plains Hospital

Completed

The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300

End Stage Renal Disease on Dialysis

United States
Memorial Sloan Kettering Cancer Center

Completed

Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation

Multiple Myeloma

United States
Umeå University

Completed

Hyperosmolality and Acute Kidney Injury After Cardiac Surgery

Acute Kidney Injury | Cardiopulmonary Bypass | Osmolality Disturbance

Sweden
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

Kidney Cancer

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
University Medical Center Groningen
Jan Kornelis de Cock Foundation

Completed

Effect of Plasma Sodium Concentration on Blood Pressure Regulators During Hemodialysis

Patients With End Stage Renal Disease on Hemodialysis

Netherlands
Stefan Soderberg
University of Edinburgh

Completed

Leptin Infusion and Endothelial Vasomotor Response (LIVARM)

Obesity | Endothelial Dysfunction | Vasodilation | Venous Occlusion Plethysmography

Sweden, United Kingdom
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment (IRMYG)

Multiple Myeloma | Renal Failure

France, Belgium, Algeria, Lebanon
Emory University

Completed

A Low ChloridE hyperTonic Solution for Brain Edema (ACETATE)

Acute Kidney Injury | Subarachnoid Hemorrhage

United States
National Cancer Institute (NCI)

Completed

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

Burkitt Lymphoma | Plasmablastic Lymphoma | Diffuse Large B-cell Lymphoma, c-MYC Positive

United States
Oncopeptides AB

Terminated

PK of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With RRMM and Impaired Renal Function (BRIDGE)

Multiple Myeloma | Renal Impairment

Greece, Czechia, Poland
Karolinska University Hospital

Suspended

Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis.

Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Diabetic Nephropathies

Sweden
Brigham and Women's Hospital

Active, not recruiting

Lysine-specific Demethylase 1 and Salt-sensitivity in Humans

Healthy Subjects

United States
Sanofi

Completed

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants

Renal Impairment

United States, Germany
Oncopeptides AB

Terminated

Study of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMM (ANCHOR)

Multiple Myeloma

United States, France, Spain, Czechia
The University of Queensland
Baxter Healthcare Corporation; Health Research Council, New Zealand; Australian...

Completed

Better Evidence for Selecting Transplant Fluids (BEST-Fluids)

End Stage Kidney Disease | Kidney Transplant; Complications | Delayed Graft Function

Australia, New Zealand
Massachusetts General Hospital

Completed

Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

Multiple Myeloma | Amyloidosis

United States
Zhongshan Ophthalmic Center, Sun Yat-sen University

Completed

Changes of Trace Elements in Aqueous Humor, Blood and Tears and Analysis of Related Factors

Primary Glaucoma

China
Scripps Health

Completed

Nonmyeloablative Allogeneic Transplant (Mini-allo)

Melanoma | Sarcoma | Renal Cell Carcinoma | Breast Cancer | Multiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Ovarian Cancer | Thymoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia and other conditions

United States
Centre hospitalier de l'Université de Montréal...
Sunnybrook Health Sciences Centre; University of Alberta; Unity Health Toronto; University of Kentucky and other collaborators

Completed

Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury (ECHO-AKI)

Acute Kidney Injury | Ultrasonography | Fluid Overload

Canada, United States
Celgene

Completed

Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal) (POM Renal)

Multiple Myeloma | Renal Impairment

United States, Canada
University of Colorado, Denver

Enrolling by invitation

Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study (HEIRitage)

Obesity | Diabetic Kidney Disease | Diabetic Nephropathies | Type 2 Diabetes | Adolescent Obesity | Nephropathy | Diabetes Type 2

United States
University of Nebraska

Active, not recruiting

Vitamin D Replacement After Kidney Transplant

Vitamin D Deficiency | Kidney Transplantation

United States
Università degli Studi di Ferrara

Completed

Effects of Red Blood Cells Transfusion on Renal Blood Flow

Anemia | Acute Kidney Injury | Fluid Overload | Transfusion-Associated Circulatory Overload

Italy
Minsk Scientific-Practical Center for Surgery,...
Belarusian State Medical University

Completed

Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents

Multiple Myeloma | Febrile Neutropenia | Pneumococcal Pneumonia | Pneumococcal Infection

Belarus
Central Clinical Hospital of the Russian Academy...
Ural State Medical University; De Haar Research Task Force; De Haar Research... and other collaborators

Terminated

Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging (REALITY)

Coronary Artery Disease | Alzheimer Disease | Contrast-induced Nephropathy | Coronary Atherosclerosis | Cerebrovascular Disease | Stable Chronic Angina | Chronic Coronary Insufficiency

Netherlands, Russian Federation, Estonia
VA Office of Research and Development

Completed

Phosphate Lowering in CKD Trial

Cardiovascular Disease | Chronic Kidney Disease

United States
National Taiwan University Hospital

Completed

Smell, Taste, Salivary Flow, and Oral Health in Patient Receiving Dialysis: A Before and After Study.

ESRD

Taiwan
Bayer

Terminated

Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease

Moderate Chronic Kidney Disease

Denmark
CytoSorbents, Inc

Terminated

CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery (REFRESH II-AKI)

Elective Cardiac Surgery

United States
CSL Behring

Terminated

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Antibody-mediated Rejection

United States, Spain, France, Netherlands, United Kingdom, Belgium, Germany
Charite University, Berlin, Germany
Berlin Institute of Health

Active, not recruiting

Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis

Glomerulonephritis Acute

United Kingdom, Germany
First Affiliated Hospital, Sun Yat-Sen University

Completed

Effects of Continuous Veno-venous Haemofiltration on Plasma Lactate in Critically Ill Patients

Kidney Injury, Acute

China
Roswell Park Cancer Institute

Completed

Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer

Melanoma | Soft Tissue Sarcoma | Breast Carcinoma | Lung Carcinoma | Malignant Neoplasm | Colon Carcinoma | Ovarian Neoplasm | Malignant Head and Neck Neoplasm | Adult Liver Carcinoma | Kidney Neoplasm

United States
OHSU Knight Cancer Institute
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

Chronic Myeloproliferative Disorders | Fanconi Anemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Celgene

Completed

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Multiple Myeloma

United States, Japan
National Cancer Institute, Egypt

Completed

Intraoperative Norepinephrine Versus Fresh Frozen Plasma in Patients Undergoing HIPEC to Reduce Renal Insult

Anesthesia

Egypt
Celgene

Completed

A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

Myelodysplastic Syndromes | Multiple Myeloma

Japan
Celgene

Completed

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Multiple Myeloma

Japan
Yuzuncu Yıl University

Completed

The Effects of Low Flow and Normal Flow Desflurane Anesthesia

Anesthesia | Geriatric | Liver Functions | Kidney Functions

Turkey
Universitätsklinikum Hamburg-Eppendorf

Completed

Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment (GMMG-DANTE)

Multiple Myeloma

Germany, Greece
Mayo Clinic
National Cancer Institute (NCI)

Completed

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade... and other conditions

United States
Universitair Ziekenhuis Brussel

Completed

Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry (MECCIAS)

Acute Renal Failure | Continuous Renal Replacement Therapy | Nutrition Poor | CO2 Removal

Belgium
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Mapping of Cardiac Power in Healthy Humans and Testing of a New Blood Pressure Sensor

Healthy Volunteers

Norway
Charite University, Berlin, Germany
Berlin Institute of Health

Active, not recruiting

Urinary T Cell Biomarker for Prediction in Lupus Nephritis

Lupus Nephritis

Germany, United Kingdom
National Cancer Institute (NCI)
NCIC Clinical Trials Group; Southwest Oncology Group; Cancer and Leukemia Group...

Completed

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery (ASSURE)

Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage II Renal Cell Cancer AJCC v7 | Stage I Renal Cell Cancer AJCC v6 and v7

United States, Canada, Puerto Rico

Search clinical trials for: Renal Plasma Flow

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations